Long-Term Assets: The sum of all assets classified as non-current.
Lantern Pharma Inc. (LTRN) had Long-Term Assets of $0.27M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-4.54M |
|
-- |
|
-- |
|
$4.77M |
|
$-4.77M |
|
$0.24M |
|
$-4.54M |
|
$-4.54M |
|
$-4.54M |
|
$-4.54M |
|
$-4.54M |
|
$-4.54M |
|
$-4.77M |
|
$-4.84M |
|
10.79M |
|
10.79M |
|
$-0.42 |
|
$-0.42 |
|
| Balance Sheet Financials | |
$20.82M |
|
$0.04M |
|
|
Long-Term Assets |
$0.27M |
$21.10M |
|
$4.29M |
|
-- |
|
$0.03M |
|
$4.32M |
|
$16.78M |
|
$16.78M |
|
$16.78M |
|
10.79M |
|
| Cash Flow Statement Financials | |
$-4.38M |
|
$3.24M |
|
-- |
|
$7.51M |
|
$6.38M |
|
$-1.13M |
|
$0.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.86 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.38M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-27.04% |
|
-27.04% |
|
-21.51% |
|
-27.04% |
|
$1.56 |
|
$-0.41 |
|
$-0.41 |
|